Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Find the perfect cards to make your season’s greetings go even further. Every pack purchased will help fund vital research and support for people living with type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Connect Immune Research partnership welcomes the Royal Free Charity
Connect Immune Research is a pioneering initiative, which unites organisations that conduct research on specific autoimmune conditions and enables them to collaborate on research projects. Autoimmune conditions involve the body’s immune system attacking its own cells instead of harmful invaders such as viruses and bacteria.
Part of the Royal Free Charity’s core work is supporting the researchers working in their hospitals and partner institutes. Their focus on early-stage research helps provide a solid foundation of knowledge that boosts the potential of other research into treatments and cures.
There is evidence that autoimmune conditions may share similar underlying biology, so Connect Immune Research is about joining forces to fund research that tackles many conditions at once.
Jon Spiers, Chief Executive of the Royal Free Charity, said: “This is a very important alliance for the health research community, and we’re delighted to add our perspective as an NHS charity with a huge research focus.
“Connect Immune Research (CIR) mirrors our commitment to collaboration: the Royal Free Charity works at the intersection of philanthropy, translational research and clinical service delivery within the NHS. Having co-funded the new Pears Building in Hampstead, home of the UCL Institute of Immunity and Transplantation, now the largest immunology institute in Europe, we look forward to working with CIR members to contribute to immunology research excellence in the UK so that together we can go further, faster, for all patients.”
The diverse range of research fields that the Royal Free Charity supports makes them a huge asset to Connect Immune Research. The UCL Institute of Immunity and Transplantation will be especially pivotal as a key research goal of theirs is to better understand the biology of immune regulation. This foundation of knowledge will help all partners to develop therapies addressing the abnormal immune system activity that occurs in each autoimmune condition.
Dr Doug Brown, CEO of the British Society of Immunology, said: “We’re delighted to welcome the Royal Free Charity to Connect Immune Research, and I know that they’ll make a valuable contribution to the work of this important initiative. The work that the Royal Free Charity does to support hospitals, NHS staff, and patients is incredibly valuable. Their involvement will help us to realise our vision of advancing treatments for people living with autoimmune conditions.”
A US clinical trial is exploring whether tegoprubart could make islet transplants an option for people with type 1 diabetes (T1D) and kidney disease, with funding from Breakthrough T1D.
The inaugural Breakthrough T1D Clinical & Research Congress (CRC) brought together more than 1,000 clinicians, researchers, industry leaders and members of the type 1 diabetes (T1D) community from around the world.
The European Association for the Study of Diabetes (EASD) is the continent's largest diabetes conference. It brought together researchers from around the world to share the latest developments in type 1 diabetes (T1D) research.
A new international position statement says people with diabetes should often be able to keep using continuous glucose monitors, insulin pumps and hybrid closed loop systems during a hospital stay, as long as it is safe and appropriate.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?